Bd-letro 2.5 mg Tablet
  1. Home
  2. Pharma Products
  3. Bdr Pharmaceuticals Internationalas Pvt Ltd
  4. Bd-letro 2.5 mg Tablet

Bd-letro 2.5 mg Tablet

Bd-Letro 2.5 mg Tablet contains letrozole, an aromatase inhibitor used as a hormonal anticancer medicine. It is mainly used for hormone receptor-positive breast cancer in postmenopausal women. Letrozole lowers estrogen production, which can help slow the growth of hormone-sensitive cancer cells.

BUY NOW

Category

Bd-Letro 2.5 mg Tablet is prescribed for eligible postmenopausal women with hormone-sensitive early or advanced breast cancer. Letrozole inhibits the aromatase enzyme responsible for converting androgens into estrogen, thereby reducing estrogen stimulation of cancer cells. It is taken orally according to the treatment plan prescribed by the oncologist and may be used as adjuvant or advanced-disease therapy. Medical monitoring may include assessment of bone health, cholesterol levels, and treatment response during long-term therapy.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer BDR Pharmaceuticals Internationals Pvt Ltd

Product Also Known As

Bd-Letro 2.5 mg Tablet, Letrozole 2.5 mg Tablet, Bd-Letro Letrozole Tablet, Letrozole Breast Cancer Tablet, Aromatase Inhibitor Tablet, Hormonal Cancer Treatment Tablet